Search Reports
Categories
Categories

Global Prenatal Screening Market

Global Prenatal Screening Market Research Report 2025(Status and Outlook)

Report Code : SER7250
Published Date : 17 July, 1905 | No of Pages: 112

  • Report Description
  • Table of Contents
  • Companies Mentioned
  • Related Reports


Report Overview
Prenatal screening refers to a range of medical tests conducted during pregnancy to assess the risk of certain genetic or chromosomal abnormalities in the fetus, such as Down syndrome, trisomy 18, and neural tube defects. These tests typically include non-invasive methods like maternal blood tests (e.g., cell-free DNA testing, first-trimester combined screening) and ultrasound examinations, as well as more invasive diagnostic procedures like amniocentesis or chorionic villus sampling (CVS) if initial screenings indicate higher risk. The primary objective is early detection to enable informed decision-making for expectant parents and healthcare providers, improving pregnancy management and neonatal outcomes. The market for prenatal screening has grown significantly due to advancements in genetic testing technology, increasing maternal age, rising awareness of prenatal care, and the demand for early and accurate fetal health assessments. Key drivers include the expansion of non-invasive prenatal testing (NIPT), which offers high accuracy with minimal risk compared to traditional methods, as well as supportive government initiatives and insurance coverage in many regions. However, challenges such as ethical concerns, high costs in certain markets, and varying regulatory frameworks across countries may impact adoption rates. The competitive landscape includes diagnostic companies, biotechnology firms, and healthcare providers, with continuous innovation in sequencing technologies and AI-driven analysis shaping future growth. Emerging markets in Asia-Pacific and Latin America present untapped opportunities due to improving healthcare infrastructure and rising disposable incomes.

The global Prenatal Screening market size was estimated at USD 5105.61 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.50% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Prenatal Screening market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Prenatal Screening market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Prenatal Screening market.
Global Prenatal Screening Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Laboratory Corporation of America Holdings
Sequenom
Quest Diagnostics
Illumina
GeneDx
Ariosa Diagnostics
Natera
Ravgen
Counsyl
Eurofins NTD
Premaitha Health
Prenatal Paternities

Market Segmentation (by Type)
First-Trimester Screening Tests
Second-Trimester Screening Tests
Third-Trimester Screening Tests
Diagnostic Tests

Market Segmentation (by Application)
Hospitals
Gynecology Clinics
Research Organizations

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Prenatal Screening Market
Overview of the regional outlook of the Prenatal Screening Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Prenatal Screening Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Prenatal Screening, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



  Table of Contents
  1 Research Methodology and Statistical Scope
      1.1 Market Definition and Statistical Scope of Prenatal Screening
      1.2 Key Market Segments
            1.2.1 Prenatal Screening Segment by Type
            1.2.2 Prenatal Screening Segment by Application
      1.3 Methodology & Sources of Information
            1.3.1 Research Methodology
            1.3.2 Research Process
            1.3.3 Market Breakdown and Data Triangulation
            1.3.4 Base Year
            1.3.5 Report Assumptions & Caveats
  2 Prenatal Screening Market Overview
      2.1 Global Market Overview
      2.2 Market Segment Executive Summary
      2.3 Global Market Size by Region
  3 Prenatal Screening Market Competitive Landscape
      3.1 Company Assessment Quadrant
      3.2 Global Prenatal Screening Product Life Cycle
      3.3 Global Prenatal Screening Revenue Market Share by Company (2020-2025)
      3.4 Prenatal Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      3.5 Prenatal Screening Company Headquarters, Area Served, Product Type
      3.6 Prenatal Screening Market Competitive Situation and Trends
            3.6.1 Prenatal Screening Market Concentration Rate
            3.6.2 Global 5 and 10 Largest Prenatal Screening Players Market Share by Revenue
            3.6.3 Mergers & Acquisitions, Expansion
  4 Prenatal Screening Value Chain Analysis
      4.1 Prenatal Screening Value Chain Analysis
      4.2 Midstream Market Analysis
      4.3 Downstream Customer Analysis
  5 The Development and Dynamics of Prenatal Screening Market
      5.1 Key Development Trends
      5.2 Driving Factors
      5.3 Market Challenges
      5.4 Industry News
            5.4.1 New Product Developments
            5.4.2 Mergers & Acquisitions
            5.4.3 Expansions
            5.4.4 Collaboration/Supply Contracts
      5.5 PEST Analysis
            5.5.1 Industry Policies Analysis
            5.5.2 Economic Environment Analysis
            5.5.3 Social Environment Analysis
            5.5.4 Technological Environment Analysis
      5.6 Global Prenatal Screening Market Porter's Five Forces Analysis
  6 Prenatal Screening Market Segmentation by Type
      6.1 Evaluation Matrix of Segment Market Development Potential (Type)
      6.2 Global Prenatal Screening Market Size Market Share by Type (2020-2025)
      6.3 Global Prenatal Screening Market Size Growth Rate by Type (2021-2025)
  7 Prenatal Screening Market Segmentation by Application
      7.1 Evaluation Matrix of Segment Market Development Potential (Application)
      7.2 Global Prenatal Screening Market Size (M USD) by Application (2020-2025)
      7.3 Global Prenatal Screening Sales Growth Rate by Application (2020-2025)
  8 Prenatal Screening Market Segmentation by Region
      8.1 Global Prenatal Screening Market Size by Region
            8.1.1 Global Prenatal Screening Market Size by Region
            8.1.2 Global Prenatal Screening Market Size Market Share by Region
      8.2 North America
            8.2.1 North America Prenatal Screening Market Size by Country
            8.2.2 U.S.
            8.2.3 Canada
            8.2.4 Mexico
      8.3 Europe
            8.3.1 Europe Prenatal Screening Market Size by Country
            8.3.2 Germany
            8.3.3 France
            8.3.4 U.K.
            8.3.5 Italy
            8.3.6 Spain
      8.4 Asia Pacific
            8.4.1 Asia Pacific Prenatal Screening Market Size by Region
            8.4.2 China
            8.4.3 Japan
            8.4.4 South Korea
            8.4.5 India
            8.4.6 Southeast Asia
      8.5 South America
            8.5.1 South America Prenatal Screening Market Size by Country
            8.5.2 Brazil
            8.5.3 Argentina
            8.5.4 Columbia
      8.6 Middle East and Africa
            8.6.1 Middle East and Africa Prenatal Screening Market Size by Region
            8.6.2 Saudi Arabia
            8.6.3 UAE
            8.6.4 Egypt
            8.6.5 Nigeria
            8.6.6 South Africa
  9 Key Companies Profile
      9.1 Laboratory Corporation of America Holdings
            9.1.1 Laboratory Corporation of America Holdings Basic Information
            9.1.2 Laboratory Corporation of America Holdings Prenatal Screening Product Overview
            9.1.3 Laboratory Corporation of America Holdings Prenatal Screening Product Market Performance
            9.1.4 Laboratory Corporation of America Holdings SWOT Analysis
            9.1.5 Laboratory Corporation of America Holdings Business Overview
            9.1.6 Laboratory Corporation of America Holdings Recent Developments
      9.2 Sequenom
            9.2.1 Sequenom Basic Information
            9.2.2 Sequenom Prenatal Screening Product Overview
            9.2.3 Sequenom Prenatal Screening Product Market Performance
            9.2.4 Sequenom SWOT Analysis
            9.2.5 Sequenom Business Overview
            9.2.6 Sequenom Recent Developments
      9.3 Quest Diagnostics
            9.3.1 Quest Diagnostics Basic Information
            9.3.2 Quest Diagnostics Prenatal Screening Product Overview
            9.3.3 Quest Diagnostics Prenatal Screening Product Market Performance
            9.3.4 Quest Diagnostics SWOT Analysis
            9.3.5 Quest Diagnostics Business Overview
            9.3.6 Quest Diagnostics Recent Developments
      9.4 Illumina
            9.4.1 Illumina Basic Information
            9.4.2 Illumina Prenatal Screening Product Overview
            9.4.3 Illumina Prenatal Screening Product Market Performance
            9.4.4 Illumina Business Overview
            9.4.5 Illumina Recent Developments
      9.5 GeneDx
            9.5.1 GeneDx Basic Information
            9.5.2 GeneDx Prenatal Screening Product Overview
            9.5.3 GeneDx Prenatal Screening Product Market Performance
            9.5.4 GeneDx Business Overview
            9.5.5 GeneDx Recent Developments
      9.6 Ariosa Diagnostics
            9.6.1 Ariosa Diagnostics Basic Information
            9.6.2 Ariosa Diagnostics Prenatal Screening Product Overview
            9.6.3 Ariosa Diagnostics Prenatal Screening Product Market Performance
            9.6.4 Ariosa Diagnostics Business Overview
            9.6.5 Ariosa Diagnostics Recent Developments
      9.7 Natera
            9.7.1 Natera Basic Information
            9.7.2 Natera Prenatal Screening Product Overview
            9.7.3 Natera Prenatal Screening Product Market Performance
            9.7.4 Natera Business Overview
            9.7.5 Natera Recent Developments
      9.8 Ravgen
            9.8.1 Ravgen Basic Information
            9.8.2 Ravgen Prenatal Screening Product Overview
            9.8.3 Ravgen Prenatal Screening Product Market Performance
            9.8.4 Ravgen Business Overview
            9.8.5 Ravgen Recent Developments
      9.9 Counsyl
            9.9.1 Counsyl Basic Information
            9.9.2 Counsyl Prenatal Screening Product Overview
            9.9.3 Counsyl Prenatal Screening Product Market Performance
            9.9.4 Counsyl Business Overview
            9.9.5 Counsyl Recent Developments
      9.10 Eurofins NTD
            9.10.1 Eurofins NTD Basic Information
            9.10.2 Eurofins NTD Prenatal Screening Product Overview
            9.10.3 Eurofins NTD Prenatal Screening Product Market Performance
            9.10.4 Eurofins NTD Business Overview
            9.10.5 Eurofins NTD Recent Developments
      9.11 Premaitha Health
            9.11.1 Premaitha Health Basic Information
            9.11.2 Premaitha Health Prenatal Screening Product Overview
            9.11.3 Premaitha Health Prenatal Screening Product Market Performance
            9.11.4 Premaitha Health Business Overview
            9.11.5 Premaitha Health Recent Developments
      9.12 Prenatal Paternities
            9.12.1 Prenatal Paternities Basic Information
            9.12.2 Prenatal Paternities Prenatal Screening Product Overview
            9.12.3 Prenatal Paternities Prenatal Screening Product Market Performance
            9.12.4 Prenatal Paternities Business Overview
            9.12.5 Prenatal Paternities Recent Developments
  10 Prenatal Screening Market Forecast by Region
      10.1 Global Prenatal Screening Market Size Forecast
      10.2 Global Prenatal Screening Market Forecast by Region
            10.2.1 North America Market Size Forecast by Country
            10.2.2 Europe Prenatal Screening Market Size Forecast by Country
            10.2.3 Asia Pacific Prenatal Screening Market Size Forecast by Region
            10.2.4 South America Prenatal Screening Market Size Forecast by Country
            10.2.5 Middle East and Africa Forecasted Sales of Prenatal Screening by Country
  11 Forecast Market by Type and by Application (2026-2033)
      11.1 Global Prenatal Screening Market Forecast by Type (2026-2033)
      11.2 Global Prenatal Screening Market Forecast by Application (2026-2033)
  12 Conclusion and Key Findings
Laboratory Corporation of America Holdings
Sequenom
Quest Diagnostics
Illumina
GeneDx
Ariosa Diagnostics
Natera
Ravgen
Counsyl
Eurofins NTD
Premaitha Health
Prenatal Paternities
Please select License
Single User Price:$ 3200
Site License Price:$ 6400
Enterprise Price:$ 6400